CC-486 and Venetoclax for Acute Myeloid Leukemia

NCT05287568 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

AML

Interventions

DRUG: Venetoclax
DRUG: CC-486

Sponsor

University of Colorado, Denver

Collaborators

[object Object]